Aldagen , Inc

ALDAGEN, Inc. is creating a significant franchise in tissue repair and regeneration, with initial focus on the treatment of cardiovascular disease and peripheral artery disease.
The Company´s proprietary product, ALDESORT, provides identification, isolation and therapeutic administration of a unique population of adult stem cells. These therapeutic cell populations have shown impressive potential to replace lost, damaged or diseased tissues in animal models and are now being tested in human clinical trials.

To support ALDESORT´s clinical development, the Company has established efficient and effective quality, manufacturing, and regulatory operations that satisfy FDA regulations.

ALDAGEN's experienced management team, unique technology and strong intellectual property position provide solid footing for the Company to become a leader in regenerative medicine.

Contact Details: 2810 Meridian Parkway Suite 148 Durham North Carolina 27713 United States of America Tel: 919-484-2571 Fax: 919-484-8792 Email: info@aldagen.com WWW: www.stemcobiomedical.com/

Loading...

Press Releases on Aldagen , Inc:
Stem Cell Product Commercialization Focus of Summit	7th January, 2009	RRY Publications	PHILADELPHIA, Jan. 7 /PRNewswire/ -- RRY Publications announced that the 4th Annual Stem Cell Summit, the premier gathering of stem cell company executives, scientists and investors, will focus on
Preliminary Lineup Set for 4th Annual Stem Cell Summit	12th August, 2008	RRY Publications	PHILADELPHIA, Aug. 12 /PRNewswire/ -- RRY Publications today announced the preliminary lineup of presenters for the 4th Annual Stem Cell Summit, the premier gathering of stem cell company

BioNews Results for Aldagen , Inc:
Clinical Data on Aldagen's Cardiovascular Therapies to Be Presented at the American Heart Association Scientif	Genetic Engineering News:  Nov 10 2009 5:33PM Matching: aldagen inc
Clinical Data on Aldagen's Cardiovascular Therapies to Be Presented at the American Heart Association Scientif	Pharmacy Choice:  Nov 10 2009 9:29PM Matching: aldagen inc
Aldagen, Inc. (ALDH) Files for $80.5 Million IPO	BioSpace:  Nov 2 2009 7:34PM Matching: aldagen inc
Aldagen refiles for IPO, raises $7.3M of $10M in debt, warrants	TechJournal South:  Oct 30 2009 10:21AM Matching: aldagen inc
Aldagen files for $80.5M IPO [The Herald-Sun, Durham, N.C.]	Therapeutics Daily:  Oct 29 2009 4:55PM Matching: aldagen inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Aldagen , Inc news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 210 times since April 2007, the link to the organisation's website has been followed 44 times

Search for more companies in Durham

Search for more companies in North Carolina

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Aldagen , Inc